IMPEDIMED LIMITED (IPD)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

IPD - IMPEDIMED LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.01
Index:
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.059
23 Mar |
OPEN $0.06 |
HIGH $0.06 |
957,901 LOW $0.06 |
TARGET | |||||
|
OTHER COMPANIES IN THE SAME SECTOR | |||
ELX . PGC . AHZ . COH . FPH . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . PEB . AT1 . CBL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 1.2 | - 1.1 | xxx |
DPS (cps) | xxx | 0.0 | 0.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | N/A | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | N/A | xxx |
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -1.2 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 10.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 2.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -15.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -188.09 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -51.92 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -51.81 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -42.78 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -51.92 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -54.99 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -15.7 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | - |
Total Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 3 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 41 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.12 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 5.2 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 49.41 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 24 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 8 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 1 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
IPD STOCK CHART

FNArena News on IPD
1 |
FNArena Corporate Results Monitor – 27-02-2023Feb 27 2023 - Australia |
2 |
Australian Broker Call *Extra* Edition – Feb 14, 2023Feb 14 2023 - Daily Market Reports |
3 |
Australian Broker Call *Extra* Edition – Feb 10, 2023Feb 10 2023 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – Oct 27, 2022Oct 27 2022 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Sep 07, 2022Sep 07 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |
2 |
Dr Boreham’s Crucible: CochlearMar 03 2023 - Australia |
3 |
Dr Boreham’s Crucible: Imagion BiosystemsFeb 13 2023 - Small Caps |
4 |
ResMed: Philips Remains The Big UnknownJan 31 2023 - Australia |
5 |
Nanosonics Outlook Remains CloudedJan 24 2023 - Small Caps |
6 |
Nanosonics Recovers On Less Negative SentimentNov 29 2022 - Small Caps |
7 |
Treasure Chest: Fisher & Paykel HealthcareNov 16 2022 - Treasure Chest |
8 |
Dr Boreham’s Crucible: Imricor Medical SystemsOct 17 2022 - Small Caps |
9 |
Market Share Gains Key to ResMed’s OutlookAug 15 2022 - Australia |
10 |
Dr Boreham’s Crucible: 4D MedicalAug 08 2022 - Small Caps |